Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by VICKIE R SHANNON and AJAY SHESHADRI.
VICKIE R SHANNON
Connection Strength
2.649
AJAY SHESHADRI
  1. Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis. Clin Lung Cancer. 2024 Nov; 25(7):624-633.e2.
    View in: PubMed
    Score: 0.243
  2. Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. Oncologist. 2023 Nov 02; 28(11):e1065-e1074.
    View in: PubMed
    Score: 0.231
  3. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol. 2023; 14:1249511.
    View in: PubMed
    Score: 0.230
  4. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study. Cancer Med. 2023 09; 12(17):17753-17765.
    View in: PubMed
    Score: 0.228
  5. Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer. Clin Oncol (R Coll Radiol). 2023 10; 35(10):630-639.
    View in: PubMed
    Score: 0.226
  6. Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature. J Immunother Precis Oncol. 2023 May; 6(2):111-116.
    View in: PubMed
    Score: 0.221
  7. Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer. 2022 07 15; 128(14):2736-2745.
    View in: PubMed
    Score: 0.208
  8. Pulmonary Function Testing in Patients with Tracheostomies: Feasibility and Technical Considerations. Lung. 2021 06; 199(3):307-310.
    View in: PubMed
    Score: 0.193
  9. Pulmonary Toxicities of Immunotherapy. Adv Exp Med Biol. 2021; 1342:357-375.
    View in: PubMed
    Score: 0.190
  10. Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2020; 1244:255-269.
    View in: PubMed
    Score: 0.177
  11. Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2018; 995:131-149.
    View in: PubMed
    Score: 0.154
  12. Gravity- vs?Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study. Chest. 2024 Dec; 166(6):1573-1582.
    View in: PubMed
    Score: 0.061
  13. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis. 2023 11 28; 228(11):1549-1558.
    View in: PubMed
    Score: 0.058
  14. Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications. Front Immunol. 2020; 11:590494.
    View in: PubMed
    Score: 0.048
  15. Complications following symptom-limited thoracentesis using suction. Eur Respir J. 2020 11; 56(5).
    View in: PubMed
    Score: 0.047
  16. Role of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis. J Immunother Precis Oncol. 2020 Nov; 3(4):172-174.
    View in: PubMed
    Score: 0.047
  17. Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study. J Bronchology Interv Pulmonol. 2020 Jan; 27(1):4-13.
    View in: PubMed
    Score: 0.044
  18. Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer Patients. Am J Med. 2020 02; 133(2):240-244.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.